# A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With Reduced Kidney Function

> **NCT07315360** · PHASE1 · RECRUITING · sponsor: **Pfizer** · enrollment: 28 (estimated)

## Conditions studied

- Renal Impairment
- Healthy

## Interventions

- **DRUG:** PF-07328948

## Key facts

- **NCT ID:** NCT07315360
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-28
- **Primary completion:** 2027-03-13
- **Final completion:** 2027-03-13
- **Target enrollment:** 28 (ESTIMATED)
- **Last updated:** 2026-05-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07315360

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07315360, "A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With Reduced Kidney Function". Retrieved via AI Analytics 2026-09-22 from https://api.ai-analytics.org/clinical/NCT07315360. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
